Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
Tsukita Y, Tozuka T, Kushiro K, Hosokawa S, Sumi T, Uematsu M, Honjo O, Yamaguchi O, Asao T, Sugisaka J, Saito G, Shiihara J, Morita R, Katakura S, Yasuda T, Hisakane K, Miyauchi E, Morita S, Kobayashi K, Asahina H. Tsukita Y, et al. Among authors: asao t. JAMA Oncol. 2024 Apr 1;10(4):439-447. doi: 10.1001/jamaoncol.2023.6277. JAMA Oncol. 2024. PMID: 38451530
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Nishioka N, Imai H, Endo M, Notsu A, Doshita K, Igawa S, Yokouchi H, Ninomiya T, Tokito T, Soda S, Fujiwara T, Asao T, Nakamichi S, Kawamura T, Inomata M, Nakashima K, Ito K, Goto Y, Umeda Y, Hirai S, Ushio R, Yokoo K, Takeda T, Fukui T, Ishihara M, Osaki T, Kubo S, Fujiwara T, Yamamoto C, Tsuda T, Tamura N, Hosokawa S, Chihara Y, Ikeda S, Furuya N, Nakahara Y, Miura S, Okamoto H. Nishioka N, et al. Among authors: asao t. Target Oncol. 2024 May;19(3):423-433. doi: 10.1007/s11523-024-01048-x. Epub 2024 Apr 13. Target Oncol. 2024. PMID: 38613731 Free PMC article.
Genomic profiling and metastatic risk in early-stage non-small cell lung cancer.
Fick CN, Dunne EG, Lankadasari MB, Mastrogiacomo B, Asao T, Vanstraelen S, Liu Y, Sanchez-Vega F, Jones DR. Fick CN, et al. Among authors: asao t. JTCVS Open. 2023 Oct 18;16:9-16. doi: 10.1016/j.xjon.2023.10.016. eCollection 2023 Dec. JTCVS Open. 2023. PMID: 38204702 Free PMC article. No abstract available.
Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy.
Masui Y, Shukuya T, Kataoka S, Shiozaki H, Kurokawa K, Nakamura I, Miyawaki T, Koinuma Y, Asao T, Kanemaru R, Shimamura SS, Mimori T, Mitsuishi Y, Tajima K, Shimada N, Takahashi K. Masui Y, et al. Among authors: asao t. Thorac Cancer. 2024 Nov;15(32):2291-2297. doi: 10.1111/1759-7714.15457. Epub 2024 Oct 7. Thorac Cancer. 2024. PMID: 39375951 Free PMC article.
Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer.
Matsumoto N, Tajima K, Takahashi F, Mitsuishi Y, Wirawan A, Hidayat M, Winardi W, Wibowo A, Hayakawa D, Izumi K, Kanamori K, Miyashita Y, Handa T, Asao T, Ko R, Shukuya T, Shimada N, Takamochi K, Hayashi T, Suzuki K, Takahashi K. Matsumoto N, et al. Among authors: asao t. Respir Investig. 2024 Sep;62(5):901-909. doi: 10.1016/j.resinv.2024.07.014. Epub 2024 Aug 7. Respir Investig. 2024. PMID: 39116798 Free article.
Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief Report.
Kurokawa K, Asao T, Hayashi T, Kishikawa S, Kanamori K, Shukuya T, Miyashita Y, Nakamura I, Miyawaki T, Kanemaru R, Mimori T, Mitsuishi Y, Tajima K, Shimada N, Takahashi F, Takamochi K, Suzuki K, Takahashi K. Kurokawa K, et al. Among authors: asao t. JTO Clin Res Rep. 2024 May 29;5(7):100693. doi: 10.1016/j.jtocrr.2024.100693. eCollection 2024 Jul. JTO Clin Res Rep. 2024. PMID: 39034967 Free PMC article.
Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).
Asao T, Shukuya T, Uemura K, Kitadai R, Yamamoto G, Mouri A, Tamaoka M, Imai R, Tsukita Y, Isobe K, Watanabe S, Kamimura M, Morita R, Kudo K, Inomata M, Tateishi K, Kakinuma K, Yoshioka H, Namba Y, Sumiyoshi I, Nakagawa T, Watanabe K, Kobayashi K, Takahashi K. Asao T, et al. Lung Cancer. 2024 Aug;194:107894. doi: 10.1016/j.lungcan.2024.107894. Epub 2024 Jul 14. Lung Cancer. 2024. PMID: 39029359
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older.
Yagishita S, Yamanaka Y, Kurata T, Watanabe K, Hosomi Y, Horinouchi H, Ohe Y, Nakahara Y, Naoki K, Asao T, Takahashi K, Saeki S, Sakagami T, Nakashima K, Tsubata Y, Fujita Y, Wakui H, Furuta M, Konishi JS, Ohuchi M, Ando Y, Mizugaki H, Hamada A. Yagishita S, et al. Among authors: asao t. Clin Pharmacol Ther. 2024 Oct;116(4):1042-1051. doi: 10.1002/cpt.3339. Epub 2024 Jun 17. Clin Pharmacol Ther. 2024. PMID: 38887810
490 results